Harrow Health Inc
NASDAQ:HROW

Watchlist Manager
Harrow Health Inc Logo
Harrow Health Inc
NASDAQ:HROW
Watchlist
Price: 42.9 USD -2.23% Market Closed
Market Cap: 1.5B USD
Have any thoughts about
Harrow Health Inc?
Write Note

Intrinsic Value

The intrinsic value of one HROW stock under the Base Case scenario is 45.19 USD. Compared to the current market price of 42.9 USD, Harrow Health Inc is Undervalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HROW Intrinsic Value
45.19 USD
Undervaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Harrow Health Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for HROW cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about HROW?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Harrow Health Inc

Provide an overview of the primary business activities
of Harrow Health Inc.

What unique competitive advantages
does Harrow Health Inc hold over its rivals?

What risks and challenges
does Harrow Health Inc face in the near future?

Has there been any significant insider trading activity
in Harrow Health Inc recently?

Summarize the latest earnings call
of Harrow Health Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Harrow Health Inc.

Provide P/S
for Harrow Health Inc.

Provide P/E
for Harrow Health Inc.

Provide P/OCF
for Harrow Health Inc.

Provide P/FCFE
for Harrow Health Inc.

Provide P/B
for Harrow Health Inc.

Provide EV/S
for Harrow Health Inc.

Provide EV/GP
for Harrow Health Inc.

Provide EV/EBITDA
for Harrow Health Inc.

Provide EV/EBIT
for Harrow Health Inc.

Provide EV/OCF
for Harrow Health Inc.

Provide EV/FCFF
for Harrow Health Inc.

Provide EV/IC
for Harrow Health Inc.

Show me price targets
for Harrow Health Inc made by professional analysts.

What are the Revenue projections
for Harrow Health Inc?

How accurate were the past Revenue estimates
for Harrow Health Inc?

What are the Net Income projections
for Harrow Health Inc?

How accurate were the past Net Income estimates
for Harrow Health Inc?

What are the EPS projections
for Harrow Health Inc?

How accurate were the past EPS estimates
for Harrow Health Inc?

What are the EBIT projections
for Harrow Health Inc?

How accurate were the past EBIT estimates
for Harrow Health Inc?

Compare the revenue forecasts
for Harrow Health Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Harrow Health Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Harrow Health Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Harrow Health Inc compared to its peers.

Compare the P/E ratios
of Harrow Health Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Harrow Health Inc with its peers.

Analyze the financial leverage
of Harrow Health Inc compared to its main competitors.

Show all profitability ratios
for Harrow Health Inc.

Provide ROE
for Harrow Health Inc.

Provide ROA
for Harrow Health Inc.

Provide ROIC
for Harrow Health Inc.

Provide ROCE
for Harrow Health Inc.

Provide Gross Margin
for Harrow Health Inc.

Provide Operating Margin
for Harrow Health Inc.

Provide Net Margin
for Harrow Health Inc.

Provide FCF Margin
for Harrow Health Inc.

Show all solvency ratios
for Harrow Health Inc.

Provide D/E Ratio
for Harrow Health Inc.

Provide D/A Ratio
for Harrow Health Inc.

Provide Interest Coverage Ratio
for Harrow Health Inc.

Provide Altman Z-Score Ratio
for Harrow Health Inc.

Provide Quick Ratio
for Harrow Health Inc.

Provide Current Ratio
for Harrow Health Inc.

Provide Cash Ratio
for Harrow Health Inc.

What is the historical Revenue growth
over the last 5 years for Harrow Health Inc?

What is the historical Net Income growth
over the last 5 years for Harrow Health Inc?

What is the current Free Cash Flow
of Harrow Health Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Harrow Health Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Harrow Health Inc

Current Assets 147.1m
Cash & Short-Term Investments 72.6m
Receivables 54.3m
Other Current Assets 20.1m
Non-Current Assets 204.5m
PP&E 13m
Intangibles 191.5m
Current Liabilities 95m
Accounts Payable 23.2m
Accrued Liabilities 34.7m
Other Current Liabilities 37.1m
Non-Current Liabilities 198.6m
Long-Term Debt 186.1m
Other Non-Current Liabilities 12.5m
Efficiency

Earnings Waterfall
Harrow Health Inc

Revenue
169.1m USD
Cost of Revenue
-46.4m USD
Gross Profit
122.7m USD
Operating Expenses
-131.3m USD
Operating Income
-8.6m USD
Other Expenses
-24.8m USD
Net Income
-33.4m USD

Free Cash Flow Analysis
Harrow Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

HROW Profitability Score
Profitability Due Diligence

Harrow Health Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
38/100
Profitability
Score

Harrow Health Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

HROW Solvency Score
Solvency Due Diligence

Harrow Health Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Average Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
35/100
Solvency
Score

Harrow Health Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HROW Price Targets Summary
Harrow Health Inc

Wall Street analysts forecast HROW stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HROW is 62.07 USD with a low forecast of 50.9 USD and a high forecast of 76.65 USD.

Lowest
Price Target
50.9 USD
19% Upside
Average
Price Target
62.07 USD
45% Upside
Highest
Price Target
76.65 USD
79% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HROW?

Click here to dive deeper.

Dividends

Harrow Health Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for HROW is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

HROW Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Harrow Health Inc Logo
Harrow Health Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

1.5B USD

Dividend Yield

0%

Description

Harrow Health, Inc. engages in the development, production, and sale of innovative medications. The company is headquartered in Nashville, Tennessee and currently employs 182 full-time employees. The company went IPO on 2013-02-08. The firm owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical business, and Visionology, a direct-to-consumer eye care subsidiary focused on chronic eye disease. The firm holds non-controlling equity positions in Eton Pharmaceuticals, Surface Ophthalmics and Melt Pharmaceuticals. The firm also owns royalty rights in four clinical stage drug candidates, which are being developed by Surface Ophthalmics and Melt Pharmaceuticals.

Contact

TENNESSEE
Nashville
102 Woodmont Blvd, Suite 610
+16157334731.0
www.harrowinc.com

IPO

2013-02-08

Employees

182

Officers

CEO & Chairman of the Board
Mr. Mark L. Baum J.D.
CFO & Corporate Secretary
Mr. Andrew R. Boll C.F.A., C.M.A.
Chief Commercial Officer
Mr. John P. Saharek MBA
Chief Scientific Officer
Dr. Dennis E Saadeh Pharm.D.
Director of Communications & Investor Relations
Ms. Jamie Webb
Vice President of Legal & Compliance
Mr. Brett A. Burrell
Show More
Chief Talent Officer`
Ms. Kim Barratt
Head of Regulatory Affairs & Pharmacovigilance
Dr. Mark A. Mannebach Ph.D., R.Ph.
Senior VP & Head of Commercial
Mr. Greg DiPasquale
Show Less

See Also

Discover More
What is the Intrinsic Value of one HROW stock?

The intrinsic value of one HROW stock under the Base Case scenario is 45.19 USD.

Is HROW stock undervalued or overvalued?

Compared to the current market price of 42.9 USD, Harrow Health Inc is Undervalued by 5%.

Back to Top